A tightly controlled New Zealand program lets two psychiatrists prescribe pharmaceutical-grade MDMA for select adults with PTSD. Here’s how it works, the evidence behind it, and what DMV readers should watch.

Psychedelic Science Review reports a rapid rise in psilocybin interest, with 100+ clinical trials since the early 2000s and recent studies signaling strong therapeutic potential.